The journal of nutrition, health & aging

, Volume 14, Issue 3, pp 203–206

Non-pharmacologic management of sleep disturbance in Alzheimer’s disease

  • R. David
  • J. Zeitzer
  • L. Friedman
  • A. Noda
  • R. O’hara
  • P. Robert
  • Jerome A. Yesavage
JNHA: Clinical Neurosciences

Abstract

Sleep and wake in Alzheimer’s disease (AD) are often fragmented as manifested by bouts of wakefulness at night and napping during the day. Management of sleep disturbances in AD is important because of their negative impact on both patients and caregivers. Pharmacological treatments, mainly sedative-hypnotics and antipsychotics, are often used but can be associated with significant adverse effects. Non-pharmacological treatments represent a beneficial alternative approach to the management of sleep disturbances in AD since they are associated with fewer adverse effects and their efficacy can be sustained after treatment has been completed. The aim of this article is to review non-pharmacological treatments, such as sleep hygiene, sleep restriction therapy (SRT), cognitive behavioral therapy (CBT), light therapy, and continuous positive airway pressure (CPAP), for the management of sleep/wake disturbances in AD.

Key words

Alzheimer’s disease sleep/wake disturbances circadian Rhythm 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dauvilliers, Y., Insomnia in patients with neurodegenerative conditions. Sleep Med, 2007. 8Suppl 4: p. S27–34.CrossRefPubMedGoogle Scholar
  2. 2.
    Hope, T., et al., Predictors of institutionalization for people with dementia living at home with a carer. Int J Geriatr Psychiatry, 1998. 13(10): p. 682–690.CrossRefPubMedGoogle Scholar
  3. 3.
    Ancoli-Israel, S., et al., Sleep in non-institutionalized Alzheimer’s disease patients. Aging (Milano), 1994. 6(6): p. 451–458.Google Scholar
  4. 4.
    Vitiello, M.V. and S. Borson, Sleep disturbances in patients with Alzheimer’s disease: epidemiology, pathophysiology and treatment. CNS Drugs, 2001. 15(10): p. 777–796.CrossRefPubMedGoogle Scholar
  5. 5.
    Yesavage, J.A., et al., Development of diagnostic criteria for defining sleep disturbance in Alzheimer’s disease. J Geriatr Psychiatry Neurol, 2003. 16(3): p. 131–139.CrossRefPubMedGoogle Scholar
  6. 6.
    Yesavage, J.A., et al., A follow-up study of actigraphic measures in home-residing Alzheimer’s disease patients. J Geriatr Psychiatry Neurol, 1998. 11(1): p. 7–10.PubMedGoogle Scholar
  7. 7.
    Ancoli-Israel, S., et al., Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep, 1997. 20(1): p. 24–27.PubMedGoogle Scholar
  8. 8.
    Sadeh, A., et al., The role of actigraphy in the evaluation of sleep disorders. Sleep, 1995. 18(4): p. 288–302.PubMedGoogle Scholar
  9. 9.
    Cole, R.J., et al., Automatic sleep/wake identification from wrist activity. Sleep, 1992. 15(5): p. 461–469.PubMedGoogle Scholar
  10. 10.
    Wooltorton, E., Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. Cmaj, 2002. 167(11): p. 1269–1270.PubMedGoogle Scholar
  11. 11.
    Conn, D.K. and R. Madan, Use of sleep-promoting medications in nursing home residents: risks versus benefits. Drugs Aging, 2006. 23(4): p. 271–287.CrossRefPubMedGoogle Scholar
  12. 12.
    Sultzer, D.L., et al., Clinical symptom responses to atypical antipsychotic medications in Alzheimer’s disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry, 2008. 165(7): p. 844–854.CrossRefPubMedGoogle Scholar
  13. 13.
    Thapa, P.B., et al., Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents. Am J Epidemiol, 1995. 142(2): p. 202–211.PubMedGoogle Scholar
  14. 14.
    Ross, J.S. and J.R. Shua-Haim, Aricept-induced nightmares in Alzheimer’s disease: 2 case reports. J Am Geriatr Soc, 1998. 46(1): p. 119–120.PubMedGoogle Scholar
  15. 15.
    Burns, A., et al., The effects of donepezil in Alzheimer’s disease — results from a multinational trial. Dement Geriatr Cogn Disord, 1999. 10(3): p. 237–244.CrossRefPubMedGoogle Scholar
  16. 16.
    Rogers, S.L., et al., Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med, 1998. 158(9): p. 1021–1031.CrossRefPubMedGoogle Scholar
  17. 17.
    Stahl, S.M., et al., Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer’s disease. Curr Med Res Opin, 2004. 20(4): p. 517–524.CrossRefPubMedGoogle Scholar
  18. 18.
    Markowitz, J.S., et al., Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine. Sleep, 2003. 26(5): p. 602–606.PubMedGoogle Scholar
  19. 19.
    Ancoli-Israel, S., et al., Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-tohead, randomized pilot study. Alzheimer Dis Assoc Disord, 2005. 19(4): p. 240–245.CrossRefPubMedGoogle Scholar
  20. 20.
    Dijk, D.J. and C. Cajochen, Melatonin and the circadian regulation of sleep initiation, consolidation, structure, and the sleep EEG. J Biol Rhythms, 1997. 12(6): p. 627–635.CrossRefPubMedGoogle Scholar
  21. 21.
    Haimov, I., et al., Sleep disorders and melatonin rhythms in elderly people. Bmj, 1994. 309(6948): p. 167.PubMedGoogle Scholar
  22. 22.
    Kennaway, D.J., et al., Urinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature. J Pineal Res, 1999. 27(4): p. 210–220.CrossRefPubMedGoogle Scholar
  23. 23.
    Zeitzer, J.M., et al., Do plasma melatonin concentrations decline with age? Am J Med, 1999. 107(5): p. 432–436.CrossRefPubMedGoogle Scholar
  24. 24.
    Wu, Y.H. and D.F. Swaab, Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer’s disease. Sleep Med, 2007. 8(6): p. 623–636.CrossRefPubMedGoogle Scholar
  25. 25.
    Singer, C., et al., A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep, 2003. 26(7): p. 893–901.PubMedGoogle Scholar
  26. 26.
    Gehrman, P.R., et al., Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry, 2009. 17(2): p. 166–169.CrossRefPubMedGoogle Scholar
  27. 27.
    Gellis, L.A. and K.L. Lichstein, Sleep hygiene practices of good and poor sleepers in the United States: an internet-based study. Behav Ther, 2009. 40(1): p. 1–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Stepanski, E.J. and J.K. Wyatt, Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev, 2003. 7(3): p. 215–225.CrossRefPubMedGoogle Scholar
  29. 29.
    Morin, C.M., et al., Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. Jama, 1999. 281(11): p. 991–999.CrossRefPubMedGoogle Scholar
  30. 30.
    McCurry, S.M., et al., Training caregivers to change the sleep hygiene practices of patients with dementia: the NITE-AD project. J Am Geriatr Soc, 2003. 51(10): p. 1455–1460.CrossRefPubMedGoogle Scholar
  31. 31.
    Spielman, A.J., P. Saskin, and M.J. Thorpy, Treatment of chronic insomnia by restriction of time in bed. Sleep, 1987. 10(1): p. 45–56.PubMedGoogle Scholar
  32. 32.
    Friedman, L., et al., A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults. J Gerontol, 1991. 46(1): p. P1–8.PubMedGoogle Scholar
  33. 33.
    Friedman, L., et al., An actigraphic comparison of sleep restriction and sleep hygiene treatments for insomnia in older adults. J Geriatr Psychiatry Neurol, 2000. 13(1): p. 17–27.CrossRefPubMedGoogle Scholar
  34. 34.
    Morin, C.M., et al., Psychological and behavioral treatment of insomnia:update of the recent evidence (1998–2004). Sleep, 2006. 29(11): p. 1398–1414.PubMedGoogle Scholar
  35. 35.
    Wang, M.Y., S.Y. Wang, and P.S. Tsai, Cognitive behavioural therapy for primary insomnia: a systematic review. J Adv Nurs, 2005. 50(5): p. 553–564.CrossRefPubMedGoogle Scholar
  36. 36.
    Montgomery, P. and J. Dennis, Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev, 2003 (1): p. CD003161.Google Scholar
  37. 37.
    Morin, C.M., et al., Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. Jama, 2009. 301(19): p. 2005–2015.CrossRefPubMedGoogle Scholar
  38. 38.
    Wicklow, A. and C.A. Espie, Intrusive thoughts and their relationship to actigraphic measurement of sleep: towards a cognitive model of insomnia. Behav Res Ther, 2000. 38(7): p. 679–693.CrossRefPubMedGoogle Scholar
  39. 39.
    Espie, C.A., et al., A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behav Res Ther, 1989. 27(1): p. 79–88.CrossRefPubMedGoogle Scholar
  40. 40.
    Bootzin, R.R. and M.L. Perlis, Nonpharmacologic treatments of insomnia. J Clin Psychiatry, 1992. 53Suppl: p. 37–41.PubMedGoogle Scholar
  41. 41.
    Bootzin, R.R., A stimulus control treatment for insomnia Proceedings of The American Pychological Association, T.A.P. Association, Editor. 1972.Google Scholar
  42. 42.
    Nicassio, P. and R. Bootzin, A comparison of progressive relaxation and autogenic training as treatments for insomnia. J Abnorm Psychol, 1974. 83(3): p. 253–260.CrossRefPubMedGoogle Scholar
  43. 43.
    McCurry, S.M., et al., Nighttime insomnia treatment and education for Alzheimer’s disease: a randomized, controlled trial. J Am Geriatr Soc, 2005. 53(5): p. 793–802.CrossRefPubMedGoogle Scholar
  44. 44.
    Campbell, S.S., et al., Exposure to light in healthy elderly subjects and Alzheimer’s patients. Physiol Behav, 1988. 42(2): p. 141–144.CrossRefPubMedGoogle Scholar
  45. 45.
    Shochat, T., et al., Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res, 2000. 9(4): p. 373–379.CrossRefPubMedGoogle Scholar
  46. 46.
    Ancoli-Israel, S., et al., Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients. Behav Sleep Med, 2003. 1(1): p. 22–36.CrossRefPubMedGoogle Scholar
  47. 47.
    Winkler, D., et al., Treatment of seasonal affective disorder. Expert Rev Neurother, 2006. 6(7): p. 1039–1048.CrossRefPubMedGoogle Scholar
  48. 48.
    Gammack, J.K., Light therapy for insomnia in older adults. Clin Geriatr Med, 2008. 24(1): p. 139–149, viii.CrossRefPubMedGoogle Scholar
  49. 49.
    Friedman, L., et al., Scheduled bright light for treatment of insomnia in older adults. J Am Geriatr Soc, 2009. 57(3): p. 441–452.CrossRefPubMedGoogle Scholar
  50. 50.
    Dowling, G.A., et al., Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s disease. Int J Geriatr Psychiatry, 2005. 20(8): p. 738–743.CrossRefPubMedGoogle Scholar
  51. 51.
    Ancoli-Israel, S., et al., Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc, 2002. 50(2): p. 282–289.CrossRefPubMedGoogle Scholar
  52. 52.
    Dowling, G.A., et al., Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s disease. J Am Geriatr Soc, 2008. 56(2): p. 239–246.CrossRefPubMedGoogle Scholar
  53. 53.
    Janssens, J.P., et al., Sleep disordered breathing in the elderly. Aging (Milano), 2000. 12(6): p. 417–429.Google Scholar
  54. 54.
    Reynolds, C.F., 3rd, et al., Sleep apnea in Alzheimer’s dementia: correlation with mental deterioration. J Clin Psychiatry, 1985. 46(7): p. 257–261.PubMedGoogle Scholar
  55. 55.
    Hoch, C.C., et al., Sleep-disordered breathing in normal and pathologic aging. J Clin Psychiatry, 1986. 47(10): p. 499–503.PubMedGoogle Scholar
  56. 56.
    Cohen-Zion, M., et al., Changes in cognitive function associated with sleep disordered breathing in older people. J Am Geriatr Soc, 2001. 49(12): p. 1622–1627.CrossRefPubMedGoogle Scholar
  57. 57.
    Ancoli-Israel, S., et al., Cognitive effects of treating obstructive sleep apnea in Alzheimer’s disease: a randomized controlled study. J Am Geriatr Soc, 2008. 56(11): p. 2076–2081.CrossRefPubMedGoogle Scholar
  58. 58.
    Ancoli-Israel, S. and L. Ayalon, Diagnosis and treatment of sleep disorders in older adults. Am J Geriatr Psychiatry, 2006. 14(2): p. 95–103.CrossRefPubMedGoogle Scholar
  59. 59.
    Weaver, T.E. and E.R. Chasens, Continuous positive airway pressure treatment for sleep apnea in older adults. Sleep Med Rev, 2007. 11(2): p. 99–111.CrossRefPubMedGoogle Scholar
  60. 60.
    Chong, M.S., et al., Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer’s disease with sleep disordered breathing. J Am Geriatr Soc, 2006. 54(5): p. 777–781.CrossRefPubMedGoogle Scholar
  61. 61.
    Cooke, J.R., et al., Continuous positive airway pressure deepens sleep in patients with Alzheimer’s disease and obstructive sleep apnea. Sleep Med, 2009.Google Scholar
  62. 62.
    Ayalon, L., et al., Adherence to continuous positive airway pressure treatment in patients with Alzheimer’s disease and obstructive sleep apnea. Am J Geriatr Psychiatry, 2006. 14(2): p. 176–180.CrossRefPubMedGoogle Scholar

Copyright information

© Serdi and Springer Verlag France 2010

Authors and Affiliations

  • R. David
    • 3
  • J. Zeitzer
    • 1
    • 2
  • L. Friedman
    • 2
  • A. Noda
    • 2
  • R. O’hara
    • 1
    • 2
  • P. Robert
    • 3
  • Jerome A. Yesavage
    • 1
    • 2
    • 4
  1. 1.Department of Veterans Affairs Health Care SystemPalo AltoUSA
  2. 2.Department of Psychiatry and Behavioral SciencesStanford University School of MedicineStanfordUSA
  3. 3.Memory Center (CMRR)CIU-S, CHU de NiceNiceFrance
  4. 4.VA Health Care System (151Y)Palo AltoUSA

Personalised recommendations